METHADONE HYDROCHLORIDE

METHADONE HYDROCHLORIDE was reported 10919 times

METHADONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT CRANIAL NERVE NEOPLASM 16 0.6154
1 IVTH NERVE DISORDER 6 0.3333
2 ANTEMORTEM BLOOD DRUG LEVEL ABNORMAL 4 0.3077
3 RETRO-ORBITAL NEOPLASM 16 0.3019
4 VISION ABNORMAL NEONATAL 112 0.2679
5 NEONATAL HYPOACUSIS 41 0.1715
6 PHYLLODES TUMOUR 10 0.1235
7 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 18 0.1224
8 HEPATITIS C RNA 5 0.1087
9 CONGENITAL NYSTAGMUS 23 0.1085
10 BRACHIAL ARTERY ENTRAPMENT SYNDROME 4 0.1053
11 STRABISMUS CONGENITAL 14 0.0979
12 DRUG WITHDRAWAL SYNDROME NEONATAL 1434 0.0968
13 DRUG DEPENDENCE, ANTEPARTUM 5 0.0962
14 SUBSTANCE ABUSER 20 0.0881
15 LEARNING DISABILITY 465 0.0872
16 NEUROBLASTOMA RECURRENT 16 0.0788
17 DEVELOPMENTAL DELAY 507 0.0561
18 ANTI-ERYTHROPOIETIN ANTIBODY NEGATIVE 5 0.0549
19 RADIATION ASSOCIATED PAIN 10 0.0481
20 INTENTIONAL MISUSE OF DRUG DELIVERY SYSTEM 4 0.0476
21 MUSCLE TONE DISORDER 14 0.0449
22 DIABETIC WOUND 4 0.0430
23 SUBSTANCE USE 64 0.0410
24 ACCIDENTAL POISONING 55 0.0401
25 SUDDEN INFANT DEATH SYNDROME 19 0.0386
26 PIERRE ROBIN SYNDROME 8 0.0372
27 HYPERINSULINAEMIC HYPOGLYCAEMIA 7 0.0315
28 MULTIPLE DRUG OVERDOSE ACCIDENTAL 14 0.0306
29 SUBSTANCE USE DISORDER 96 0.0301
30 MYOCARDIAL FIBROSIS 25 0.0298
31 TOXICOLOGIC TEST ABNORMAL 18 0.0297
32 BRADYPNOEA 73 0.0270
33 WEIGHT DECREASE NEONATAL 5 0.0258
34 VISCERAL CONGESTION 13 0.0254
35 HOLOPROSENCEPHALY 4 0.0248
36 DRUG DIVERSION 148 0.0239
37 VICTIM OF CHILD ABUSE 6 0.0239
38 NARCOTIC INTOXICATION 6 0.0233
39 SUBSTANCE DEPENDENCE 15 0.0223
40 HEPATITIS C ANTIBODY POSITIVE 6 0.0221
41 CHEMICAL SUBMISSION 5 0.0198
42 PREMATURE LABOUR 111 0.0196
43 TOXIC LEUKOENCEPHALOPATHY 14 0.0193
44 BRACHIAL PLEXOPATHY 4 0.0181
45 FOETAL EXPOSURE DURING PREGNANCY 1458 0.0179
46 CONGENITAL DIAPHRAGMATIC HERNIA 7 0.0179
47 MYOCARDIAL OEDEMA 7 0.0177
48 MIOSIS 138 0.0172
49 CHILD ABUSE 4 0.0154
50 MULTIPLE DRUG OVERDOSE INTENTIONAL 49 0.0152
51 TORSADE DE POINTES 116 0.0148
52 EPIDURAL LIPOMATOSIS 5 0.0145
53 THYROXINE INCREASED 10 0.0142
54 ADNEXA UTERI MASS 4 0.0138
55 RESPIRATORY DEPRESSION 168 0.0137
56 DRUG USE DISORDER 113 0.0134
57 MULTIPLE DRUG OVERDOSE 65 0.0131
58 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 10 0.0127
59 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 26 0.0116
60 SUBSTANCE ABUSE 93 0.0114
61 ACCIDENTAL DEATH 21 0.0113
62 CARDIOPULMONARY FAILURE 44 0.0113
63 PREMATURE DELIVERY 179 0.0112
64 HYPERTONIA NEONATAL 6 0.0112
65 RESPIRATORY ACIDOSIS 44 0.0112
66 INTENTIONAL MISUSE 20 0.0105
67 LEUKOENCEPHALOPATHY 39 0.0105
68 FAECAL VOLUME DECREASED 5 0.0104
69 DUCTUS ARTERIOSUS PREMATURE CLOSURE 4 0.0098
70 DEPENDENCE 535 0.0097
71 BIOPSY LIVER 4 0.0097
72 DRUG ABUSE 802 0.0096
73 VICTIM OF SEXUAL ABUSE 5 0.0095
74 POLYSUBSTANCE ABUSE 6 0.0094
75 DIABETIC HYPEROSMOLAR COMA 4 0.0093
76 WHITE COAT HYPERTENSION 5 0.0092
77 HOMELESS 4 0.0090
78 CHLOASMA 4 0.0086
79 CEREBRAL HYPOPERFUSION 4 0.0086
80 POISONING 106 0.0084
81 BONE MARROW DISORDER 24 0.0079
82 ANOXIC ENCEPHALOPATHY 5 0.0078
83 EXECUTIVE DYSFUNCTION 4 0.0074
84 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 19 0.0072
85 TOXICITY TO VARIOUS AGENTS 1220 0.0072
86 ASPHYXIA 58 0.0071
87 HYPERCAPNIA 21 0.0070
88 BRAIN HYPOXIA 7 0.0070
89 ELECTROCARDIOGRAM QT PROLONGED 247 0.0069
90 SUDDEN CARDIAC DEATH 23 0.0067
91 PREMATURE BABY 201 0.0067
92 SOPOR 88 0.0066
93 CARDIO-RESPIRATORY ARREST 270 0.0065
94 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0064
95 DRUG DEPENDENCE 1033 0.0064
96 FOETAL GROWTH RETARDATION 5 0.0064
97 TOXIC ENCEPHALOPATHY 32 0.0063
98 EXPOSURE DURING PREGNANCY 392 0.0063
99 METASTASES TO SPINE 21 0.0062
100 PRODUCT TAMPERING 11 0.0061
101 HEPATIC FIBROSIS 21 0.0061
102 MATERNAL EXPOSURE DURING PREGNANCY 536 0.0060
103 DRUG LEVEL INCREASED 99 0.0060
104 ABSCESS NECK 4 0.0059
105 STOMA COMPLICATION 6 0.0059
106 DRUG ABUSER 36 0.0059
107 ACCIDENTAL OVERDOSE 214 0.0058
108 STRABISMUS 17 0.0058
109 VENTRICULAR ARRHYTHMIA 21 0.0057
110 BLOOD PRESSURE DIASTOLIC INCREASED 26 0.0056
111 MULTIPLE CONGENITAL ABNORMALITIES 8 0.0056
112 CONGENITAL ANOMALY 43 0.0055
113 LABELLED DRUG-DRUG INTERACTION ISSUE 8 0.0055
114 PILOERECTION 6 0.0055
115 ESCHAR 4 0.0055
116 RESPIRATORY ARREST 150 0.0054
117 RESPIRATORY RATE DECREASED 17 0.0054
118 COMA HEPATIC 4 0.0054
119 BRAIN HERNIATION 16 0.0054
120 MATERNAL DRUGS AFFECTING FOETUS 41 0.0053
121 INTERVERTEBRAL DISCITIS 10 0.0053
122 STRESS CARDIOMYOPATHY 30 0.0052
123 RADIATION PNEUMONITIS 11 0.0051
124 DRUG TOXICITY 70 0.0051
125 SELF-MEDICATION 21 0.0051
126 EXPOSURE VIA BREAST MILK 20 0.0050
127 HYPOGONADISM 5 0.0049
128 DILATED CARDIOMYOPATHY 5 0.0049
129 FOETAL GROWTH RESTRICTION 30 0.0049
130 DRUG EXPOSURE DURING PREGNANCY 165 0.0048
131 DRUG TOLERANCE 24 0.0047
132 MENOPAUSAL SYMPTOMS 11 0.0047
133 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 32 0.0047
134 CLEFT PALATE 9 0.0047
135 COMPLETED SUICIDE 384 0.0046
136 BLADDER DILATATION 5 0.0046
137 ASPIRATION 50 0.0046
138 DRUG SCREEN NEGATIVE 8 0.0045
139 COMPLEX PARTIAL SEIZURES 5 0.0045
140 COMA SCALE ABNORMAL 13 0.0045
141 COMA 211 0.0044
142 OVERDOSE 945 0.0044
143 PUPILS UNEQUAL 5 0.0044
144 IMMUNE THROMBOCYTOPENIA 20 0.0044
145 DISABILITY 84 0.0042
146 LONG QT SYNDROME 10 0.0042
147 CARDIAC DEATH 5 0.0041
148 MUTISM 6 0.0041
149 POISONING DELIBERATE 39 0.0041
150 HYPOVENTILATION 13 0.0040
151 NYSTAGMUS 21 0.0040
152 LEFT ATRIAL DILATATION 5 0.0039
153 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 24 0.0039
154 PULMONARY HAEMORRHAGE 30 0.0038
155 DRUG SCREEN POSITIVE 30 0.0038
156 UNRESPONSIVE TO STIMULI 97 0.0038
157 POST-TRAUMATIC STRESS DISORDER 25 0.0037
158 BONE NEOPLASM 4 0.0037
159 INCOHERENT 24 0.0037
160 TRISMUS 19 0.0037
161 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
162 NERVE INJURY 40 0.0036
163 BRAIN INJURY 36 0.0036
164 PSYCHIATRIC DECOMPENSATION 7 0.0036
165 ALCOHOL USE 13 0.0035
166 DRUG WITHDRAWAL SYNDROME 306 0.0035
167 PUPIL FIXED 6 0.0035
168 HYPOPNOEA 12 0.0035
169 SUICIDE ATTEMPT 209 0.0034
170 BILIARY DILATATION 5 0.0034
171 HYPERPARATHYROIDISM 7 0.0034
172 IMPRISONMENT 6 0.0034
173 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
174 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
175 IRITIS 10 0.0033
176 HEAT STROKE 5 0.0033
177 ESSENTIAL HYPERTENSION 6 0.0033
178 PNEUMONIA ASPIRATION 81 0.0032
179 SMALL FOR DATES BABY 16 0.0032
180 PERSECUTORY DELUSION 8 0.0032
181 MATERNAL EXPOSURE DURING BREAST FEEDING 13 0.0032
182 ELECTROCARDIOGRAM T WAVE ABNORMAL 5 0.0032
183 EMOTIONAL DISTRESS 384 0.0032
184 HEPATITIS C 38 0.0031
185 ACCIDENTAL EXPOSURE 13 0.0031
186 SUDDEN DEATH 33 0.0031
187 HEART DISEASE CONGENITAL 11 0.0031
188 BRAIN OEDEMA 39 0.0031
189 COMPARTMENT SYNDROME 8 0.0031
190 DEAFNESS NEUROSENSORY 10 0.0030
191 MYOCLONUS 36 0.0030
192 DEPRESSED LEVEL OF CONSCIOUSNESS 119 0.0030
193 ESCHERICHIA BACTERAEMIA 7 0.0030
194 PULMONARY CONGESTION 39 0.0030
195 CEREBELLAR INFARCTION 5 0.0030
196 SNORING 11 0.0029
197 ENCEPHALITIS 20 0.0029
198 WOUND INFECTION STAPHYLOCOCCAL 5 0.0029
199 ENDOCARDITIS 14 0.0027
200 GENERALISED ANXIETY DISORDER 4 0.0027
201 DISORGANISED SPEECH 5 0.0027
202 CYANOSIS 42 0.0027
203 IMPATIENCE 5 0.0027
204 WITHDRAWAL SYNDROME 111 0.0026
205 ALCOHOL ABUSE 7 0.0026
206 ACCIDENTAL DRUG INTAKE BY CHILD 4 0.0026
207 APNOEA 20 0.0026
208 NEONATAL RESPIRATORY DISTRESS SYNDROME 9 0.0025
209 ENDOTRACHEAL INTUBATION 7 0.0025
210 OXYGEN SATURATION ABNORMAL 7 0.0025
211 PULMONARY OEDEMA 109 0.0024
212 GASTROINTESTINAL MOTILITY DISORDER 13 0.0024
213 LISTLESS 8 0.0024
214 INJECTION SITE ABSCESS 6 0.0024
215 LEFT VENTRICULAR DYSFUNCTION 16 0.0024
216 CARDIAC ARREST 195 0.0024
217 CAESAREAN SECTION 27 0.0023
218 CRANIOCEREBRAL INJURY 7 0.0023
219 HYPOPITUITARISM 4 0.0023
220 PSYCHOMOTOR SKILLS IMPAIRED 6 0.0023
221 VENTRICULAR TACHYCARDIA 37 0.0022
222 SEROTONIN SYNDROME 43 0.0022
223 IDIOPATHIC INTRACRANIAL HYPERTENSION 5 0.0022
224 BEHAVIOUR DISORDER 12 0.0022
225 DELIRIUM 76 0.0022
226 RHABDOMYOLYSIS 90 0.0022
227 PSYCHOMOTOR RETARDATION 6 0.0021
228 EXPOSURE DURING BREAST FEEDING 7 0.0021
229 RADIUS FRACTURE 5 0.0021
230 DIABETES INSIPIDUS 5 0.0021
231 ESCHERICHIA SEPSIS 6 0.0021
232 SEDATION 54 0.0021
233 JUVENILE IDIOPATHIC ARTHRITIS 5 0.0020
234 DRUG INTERACTION 323 0.0020
235 LEFT VENTRICULAR FAILURE 7 0.0020
236 BODY TEMPERATURE DECREASED 20 0.0020
237 HYDROCEPHALUS 11 0.0020
238 PETECHIAE 21 0.0020
239 HYPERREFLEXIA 7 0.0020
240 HYPERAMMONAEMIA 10 0.0020
241 ENCEPHALOPATHY 49 0.0020
242 FOAMING AT MOUTH 4 0.0020
243 SEDATION COMPLICATION 5 0.0020
244 NERVE COMPRESSION 18 0.0019
245 BRAIN DEATH 6 0.0019
246 HYPOXIA 67 0.0019
247 ALTERED STATE OF CONSCIOUSNESS 41 0.0019
248 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
249 ALCOHOL POISONING 5 0.0019
250 INTENTIONAL DRUG MISUSE 39 0.0019
251 EXPOSED BONE IN JAW 4 0.0018
252 CLONUS 5 0.0018
253 BIPOLAR I DISORDER 4 0.0018
254 ACCIDENT AT WORK 4 0.0018
255 DRUG SCREEN FALSE POSITIVE 5 0.0018
256 PARANOIA 31 0.0018
257 MYDRIASIS 23 0.0018
258 POTENTIATING DRUG INTERACTION 6 0.0018
259 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
260 DRUG LEVEL ABOVE THERAPEUTIC 8 0.0017
261 VENTRICULAR EXTRASYSTOLES 18 0.0017
262 INTENTIONAL PRODUCT MISUSE 151 0.0017
263 HYPERAESTHESIA 14 0.0017
264 CARDIOMYOPATHY 25 0.0017
265 HYPOTHERMIA 17 0.0017
266 SOMNAMBULISM 11 0.0017
267 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
268 CATHETER SITE HAEMORRHAGE 4 0.0016
269 BLOOD CREATININE DECREASED 5 0.0016
270 ARTERIOSCLEROSIS 15 0.0016
271 INFUSION SITE PRURITUS 5 0.0016
272 HYPERTONIA 9 0.0016
273 STUPOR 5 0.0016
274 VASCULAR DEVICE INFECTION 7 0.0015
275 ANXIETY 437 0.0015
276 IMPAIRED QUALITY OF LIFE 22 0.0015
277 PROSTATOMEGALY 6 0.0015
278 AFFECTIVE DISORDER 12 0.0015
279 SOMNOLENCE 306 0.0015
280 NEPHROGENIC ANAEMIA 7 0.0015
281 AREFLEXIA 4 0.0015
282 LEUKOCYTOSIS 27 0.0015
283 EMPHYSEMA 15 0.0015
284 INTENTIONAL SELF-INJURY 30 0.0015
285 INTENTIONAL OVERDOSE 95 0.0015
286 HEPATIC CYST 5 0.0015
287 PULSE ABSENT 7 0.0015
288 FAECAL INCONTINENCE 7 0.0015
289 REGURGITATION 5 0.0015
290 RESPIRATION ABNORMAL 10 0.0014
291 DENTAL CARIES 16 0.0014
292 AGITATION 106 0.0014
293 HEPATOMEGALY 14 0.0014
294 HEMIPARESIS 24 0.0014
295 HYPERVOLAEMIA 7 0.0014
296 DIABETIC NEUROPATHY 7 0.0014
297 ABSCESS LIMB 6 0.0014
298 LUNG NEOPLASM 6 0.0014
299 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
300 BILIARY COLIC 4 0.0014
301 BLOOD PHOSPHORUS DECREASED 5 0.0014
302 FIBROMYALGIA 33 0.0014
303 CATATONIA 7 0.0013
304 ECONOMIC PROBLEM 20 0.0013
305 METASTASES TO LIVER 23 0.0013
306 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
307 SPINAL CORD COMPRESSION 5 0.0013
308 EUPHORIC MOOD 13 0.0013
309 JOINT RANGE OF MOTION DECREASED 17 0.0013
310 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
311 VENTRICULAR FIBRILLATION 14 0.0013
312 CANDIDIASIS 5 0.0012
313 CANDIDA INFECTION 21 0.0012
314 TRIGEMINAL NEURALGIA 5 0.0012
315 HOMICIDAL IDEATION 5 0.0012
316 HYPOPHOSPHATAEMIA 9 0.0012
317 HYPOACUSIS 52 0.0012
318 MENTAL STATUS CHANGES 33 0.0012
319 HYPERPYREXIA 5 0.0012
320 PHLEBITIS 6 0.0012
321 PURULENT DISCHARGE 5 0.0012
322 HYPOKALAEMIA 54 0.0012
323 BRONCHOPNEUMONIA 4 0.0012
324 HYPOALBUMINAEMIA 9 0.0012
325 GRANULOMA 4 0.0012
326 DRUG-INDUCED LIVER INJURY 36 0.0011
327 EXTRASYSTOLES 8 0.0011
328 CAROTID ARTERY STENOSIS 4 0.0011
329 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 55 0.0011
330 NEUROTOXICITY 20 0.0011
331 SPINAL OSTEOARTHRITIS 10 0.0011
332 SINUS BRADYCARDIA 11 0.0011
333 HYPOGLYCAEMIA 55 0.0011
334 SINUS TACHYCARDIA 16 0.0011
335 RESPIRATORY DISTRESS 31 0.0011
336 ELECTROLYTE IMBALANCE 13 0.0011
337 AGGRESSION 56 0.0011
338 DYSARTHRIA 42 0.0011
339 IRON DEFICIENCY 5 0.0011
340 LOSS OF CONSCIOUSNESS 142 0.0011
341 CARDIAC DISORDER 103 0.0011
342 HICCUPS 9 0.0011
343 FAECALOMA 6 0.0011
344 DISEASE COMPLICATION 5 0.0011
345 THERAPY NON-RESPONDER 49 0.0011
346 PROSTATIC DISORDER 6 0.0011
347 RENAL FUNCTION TEST ABNORMAL 5 0.0011
348 HYPERACUSIS 4 0.0011
349 ADRENAL INSUFFICIENCY 13 0.0011
350 ANGIOPATHY 6 0.0011
351 TOOTH LOSS 22 0.0011
352 SPINAL COLUMN STENOSIS 5 0.0011
353 RESPIRATORY FAILURE 77 0.0011
354 ERECTILE DYSFUNCTION 27 0.0011
355 SLEEP APNOEA SYNDROME 20 0.0010
356 HYPERTHERMIA 8 0.0010
357 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
358 COLITIS ISCHAEMIC 7 0.0010
359 HYPERCHOLESTEROLAEMIA 10 0.0010
360 NERVOUS SYSTEM DISORDER 32 0.0010
361 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
362 BIPOLAR DISORDER 11 0.0010
363 HYPERLIPIDAEMIA 12 0.0010
364 CORONARY ARTERY STENOSIS 5 0.0010
365 PALLOR 27 0.0010
366 FUNGAL SKIN INFECTION 4 0.0010
367 GALLBLADDER OPERATION 4 0.0010
368 PATHOLOGICAL FRACTURE 5 0.0010
369 BODY TEMPERATURE INCREASED 20 0.0010
370 AMMONIA INCREASED 5 0.0010
371 ABNORMAL FAECES 8 0.0010
372 CARDIOMEGALY 12 0.0010
373 GRAND MAL CONVULSION 9 0.0010
374 SUICIDAL IDEATION 89 0.0010
375 CACHEXIA 5 0.0010
376 FOETAL DEATH 5 0.0010
377 FAILURE TO THRIVE 5 0.0010
378 CHOLECYSTECTOMY 11 0.0010
379 PRE-EXISTING CONDITION IMPROVED 6 0.0010
380 CONGESTIVE CARDIOMYOPATHY 4 0.0010
381 MAJOR DEPRESSION 7 0.0010
382 SICKLE CELL ANAEMIA WITH CRISIS 15 0.0010
383 TACHYCARDIA 84 0.0009
384 BUNDLE BRANCH BLOCK LEFT 4 0.0009
385 INADEQUATE ANALGESIA 8 0.0009
386 HEPATIC CYTOLYSIS 12 0.0009
387 AORTIC VALVE INCOMPETENCE 4 0.0009
388 BLOOD MAGNESIUM DECREASED 8 0.0009
389 HEPATIC LESION 4 0.0009
390 MUSCLE RIGIDITY 11 0.0009
391 ACUTE MYOCARDIAL INFARCTION 27 0.0009
392 PSYCHOTIC DISORDER 27 0.0009
393 CRYING 33 0.0009
394 CARDIOGENIC SHOCK 13 0.0009
395 PURPURA 8 0.0009
396 HALLUCINATION 68 0.0009
397 PAIN 554 0.0009
398 RESTLESSNESS 33 0.0009
399 WRONG PRODUCT ADMINISTERED 6 0.0009
400 CONFUSIONAL STATE 143 0.0009
401 ACUTE RESPIRATORY FAILURE 17 0.0009
402 HYPERSOMNIA 25 0.0009
403 ISCHAEMIA 4 0.0009
404 JOINT EFFUSION 6 0.0009
405 HERPES VIRUS INFECTION 5 0.0009
406 DECUBITUS ULCER 7 0.0009
407 URINE ODOUR ABNORMAL 5 0.0008
408 DECREASED INTEREST 5 0.0008
409 PSYCHOMOTOR HYPERACTIVITY 14 0.0008
410 HEREDITARY ANGIOEDEMA 9 0.0008
411 DIABETIC KETOACIDOSIS 20 0.0008
412 OSTEOMYELITIS 15 0.0008
413 OESOPHAGITIS 9 0.0008
414 OBESITY 13 0.0008
415 RENAL TUBULAR NECROSIS 8 0.0008
416 HEPATIC STEATOSIS 15 0.0008
417 OXYGEN SATURATION DECREASED 45 0.0008
418 STATUS EPILEPTICUS 9 0.0008
419 MITRAL VALVE INCOMPETENCE 9 0.0008
420 INFUSION SITE SWELLING 5 0.0008
421 MULTIPLE INJURIES 5 0.0008
422 HAEMODYNAMIC INSTABILITY 6 0.0008
423 CONVULSION 45 0.0008
424 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
425 MOTOR DYSFUNCTION 8 0.0008
426 VISUAL IMPAIRMENT 96 0.0008
427 POOR VENOUS ACCESS 8 0.0008
428 HYPERBILIRUBINAEMIA 8 0.0008
429 APLASTIC ANAEMIA 4 0.0008
430 ARRHYTHMIA 36 0.0008
431 NEUROLEPTIC MALIGNANT SYNDROME 9 0.0008
432 PNEUMOTHORAX 12 0.0008
433 TRICUSPID VALVE INCOMPETENCE 6 0.0008
434 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
435 APPETITE DISORDER 5 0.0008
436 HEPATIC ENCEPHALOPATHY 7 0.0007
437 HEPATIC CIRRHOSIS 14 0.0007
438 NO THERAPEUTIC RESPONSE 9 0.0007
439 CONSTIPATION 160 0.0007
440 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
441 BLOOD POTASSIUM DECREASED 22 0.0007
442 SMALL INTESTINAL OBSTRUCTION 9 0.0007
443 LETHARGY 42 0.0007
444 HYPERCALCAEMIA 9 0.0007
445 INTESTINAL ISCHAEMIA 4 0.0007
446 ATELECTASIS 7 0.0007
447 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
448 ILL-DEFINED DISORDER 44 0.0007
449 LYMPHOEDEMA 5 0.0007
450 METABOLIC ACIDOSIS 23 0.0007
451 LIVE BIRTH 6 0.0007
452 COORDINATION ABNORMAL 10 0.0007
453 MENORRHAGIA 14 0.0007
454 BRAIN FOG 11 0.0007
455 MENTAL IMPAIRMENT 17 0.0007
456 SCAR 12 0.0007
457 HYPERHIDROSIS 90 0.0007
458 MYOCARDITIS 8 0.0007
459 BRADYCARDIA 37 0.0007
460 HEPATIC FAILURE 21 0.0007
461 MOOD SWINGS 22 0.0007
462 URINARY RETENTION 23 0.0007
463 ORTHOSTATIC HYPOTENSION 12 0.0007
464 DEATH 590 0.0007
465 ABNORMAL BEHAVIOUR 27 0.0007
466 DISORIENTATION 27 0.0007
467 BRADYKINESIA 4 0.0007
468 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
469 CEREBRAL DISORDER 5 0.0007
470 ATAXIA 8 0.0007
471 CARDIOTOXICITY 6 0.0007
472 DEPRESSION 153 0.0007
473 ACCIDENT 8 0.0007
474 KETOACIDOSIS 5 0.0007
475 MENTAL DISORDER 29 0.0007
476 SLEEP DISORDER 47 0.0007
477 HEPATITIS CHOLESTATIC 4 0.0007
478 TACHYPNOEA 9 0.0007
479 HEPATOCELLULAR CARCINOMA 5 0.0007
480 BLOOD UREA INCREASED 11 0.0007
481 PNEUMONIA BACTERIAL 6 0.0007
482 HYPOMAGNESAEMIA 9 0.0006
483 MUSCULOSKELETAL CHEST PAIN 10 0.0006
484 ANKLE FRACTURE 10 0.0006
485 PNEUMONIA 209 0.0006
486 ROAD TRAFFIC ACCIDENT 27 0.0006
487 MASS 9 0.0006
488 EJECTION FRACTION DECREASED 10 0.0006
489 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
490 RENAL FAILURE ACUTE 27 0.0006
491 FOOT FRACTURE 12 0.0006
492 SEIZURE 73 0.0006
493 TOOTH DISORDER 14 0.0006
494 ABSCESS 10 0.0006
495 MALNUTRITION 7 0.0006
496 PNEUMONITIS 17 0.0006
497 BLOOD CALCIUM DECREASED 7 0.0006
498 MUSCLE TIGHTNESS 10 0.0006
499 MYOCARDIAL ISCHAEMIA 7 0.0006
500 BRADYPHRENIA 4 0.0006
501 SHOCK 14 0.0006
502 PANCYTOPENIA 34 0.0006
503 RECTAL HAEMORRHAGE 26 0.0006
504 RESTLESS LEGS SYNDROME 11 0.0006
505 SPINAL COMPRESSION FRACTURE 5 0.0006
506 POOR QUALITY SLEEP 13 0.0006
507 ACUTE CORONARY SYNDROME 5 0.0006
508 SPLENOMEGALY 7 0.0006
509 PRODUCT PRESCRIBING ISSUE 13 0.0006
510 CORONARY ARTERY DISEASE 18 0.0006
511 INFUSION SITE ERYTHEMA 5 0.0006
512 BLOOD BILIRUBIN INCREASED 16 0.0006
513 SUBARACHNOID HAEMORRHAGE 6 0.0006
514 BLOOD TESTOSTERONE DECREASED 4 0.0006
515 SKIN ULCER 15 0.0006
516 CHROMATURIA 13 0.0006
517 WEIGHT FLUCTUATION 6 0.0006
518 BLOOD PRESSURE DECREASED 38 0.0006
519 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
520 HEAD INJURY 18 0.0006
521 AMNESIA 37 0.0006
522 HYPOTENSION 114 0.0006
523 COLD SWEAT 10 0.0006
524 LYMPHOPENIA 8 0.0006
525 GENERALISED OEDEMA 7 0.0006
526 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
527 HAND FRACTURE 4 0.0006
528 HAEMORRHOIDS 11 0.0006
529 CHOKING 11 0.0006
530 EXTRAPYRAMIDAL DISORDER 14 0.0006
531 DIVERTICULUM 4 0.0006
532 BRONCHOSPASM 8 0.0006
533 LOSS OF LIBIDO 5 0.0006
534 SKIN LACERATION 6 0.0006
535 PULMONARY THROMBOSIS 6 0.0005
536 BONE DISORDER 10 0.0005
537 END STAGE RENAL DISEASE 10 0.0005
538 INFUSION SITE PAIN 7 0.0005
539 BLOOD PRESSURE FLUCTUATION 13 0.0005
540 DYSKINESIA 22 0.0005
541 COAGULOPATHY 9 0.0005
542 PERSONALITY CHANGE 5 0.0005
543 FLANK PAIN 5 0.0005
544 OEDEMA PERIPHERAL 65 0.0005
545 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
546 ANGER 18 0.0005
547 DYSPNOEA EXERTIONAL 20 0.0005
548 BLOOD SODIUM DECREASED 10 0.0005
549 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 29 0.0005
550 IMPAIRED DRIVING ABILITY 6 0.0005
551 VOMITING 248 0.0005
552 SPUTUM DISCOLOURED 5 0.0005
553 INJURY 37 0.0005
554 DERMATITIS CONTACT 6 0.0005
555 DRUG DISPENSING ERROR 8 0.0005
556 ACIDOSIS 4 0.0005
557 QUALITY OF LIFE DECREASED 7 0.0005
558 GASTRIC HAEMORRHAGE 6 0.0005
559 HALLUCINATION, VISUAL 11 0.0005
560 JAUNDICE 14 0.0005
561 ATRIOVENTRICULAR BLOCK 4 0.0005
562 DELUSION 8 0.0005
563 THERAPY PARTIAL RESPONDER 8 0.0005
564 VISUAL ACUITY REDUCED 17 0.0005
565 SKIN FISSURES 10 0.0005
566 ACUTE RESPIRATORY DISTRESS SYNDROME 9 0.0005
567 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
568 FAECES DISCOLOURED 11 0.0005
569 TYPE 2 DIABETES MELLITUS 17 0.0005
570 ACCIDENTAL EXPOSURE TO PRODUCT 52 0.0005
571 HAEMATOCRIT DECREASED 10 0.0005
572 BLOOD ALBUMIN DECREASED 4 0.0005
573 PRODUCT PRESCRIBING ERROR 12 0.0005
574 CHOLECYSTITIS 6 0.0005
575 WOUND 14 0.0005
576 SALIVARY HYPERSECRETION 5 0.0005
577 TOOTHACHE 9 0.0005
578 CELLULITIS 25 0.0005
579 PRODUCT ADMINISTRATION ERROR 10 0.0005
580 HEPATOCELLULAR INJURY 7 0.0005
581 NEURALGIA 12 0.0005
582 NIGHTMARE 17 0.0005
583 PARALYSIS 7 0.0005
584 NEUTROPHIL COUNT INCREASED 5 0.0005
585 OSTEOPOROSIS 20 0.0005
586 ILLNESS 50 0.0005
587 OSTEONECROSIS OF JAW 12 0.0005
588 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
589 ILEUS 6 0.0005
590 BACK PAIN 112 0.0005
591 DRY MOUTH 39 0.0005
592 SYNCOPE 48 0.0005
593 OEDEMA 26 0.0005
594 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
595 UNINTENDED PREGNANCY 5 0.0005
596 TRANSFUSION 5 0.0005
597 PERICARDITIS 8 0.0005
598 FRACTURE 9 0.0005
599 TREATMENT NONCOMPLIANCE 26 0.0005
600 SCRATCH 5 0.0005
601 INCONTINENCE 5 0.0005
602 RENAL PAIN 5 0.0005
603 COLON CANCER 7 0.0005
604 PROCEDURAL PAIN 13 0.0005
605 RESPIRATORY DISORDER 14 0.0005
606 MEDICATION ERROR 26 0.0005
607 DYSTONIA 9 0.0005
608 ACUTE KIDNEY INJURY 71 0.0005
609 DISTURBANCE IN ATTENTION 25 0.0005
610 CARDIAC MURMUR 4 0.0005
611 OSTEOPENIA 7 0.0005
612 WEIGHT INCREASED 103 0.0005
613 DYSPEPSIA 45 0.0005
614 HYPERKALAEMIA 16 0.0005
615 GASTRITIS 12 0.0005
616 STAPHYLOCOCCAL INFECTION 15 0.0005
617 TOOTH FRACTURE 5 0.0005
618 TREMOR 75 0.0005
619 INTESTINAL OBSTRUCTION 17 0.0005
620 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
621 GALLBLADDER DISORDER 8 0.0004
622 PLEURAL EFFUSION 27 0.0004
623 BONE MARROW FAILURE 9 0.0004
624 CHEST PAIN 82 0.0004
625 ASCITES 13 0.0004
626 HALLUCINATION, AUDITORY 7 0.0004
627 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
628 ACUTE HEPATIC FAILURE 6 0.0004
629 URINARY INCONTINENCE 13 0.0004
630 HAEMOGLOBIN DECREASED 45 0.0004
631 INFUSION RELATED REACTION 29 0.0004
632 WEIGHT DECREASED 122 0.0004
633 RENAL FAILURE 58 0.0004
634 MUSCLE TWITCHING 10 0.0004
635 IRON DEFICIENCY ANAEMIA 4 0.0004
636 NECK PAIN 24 0.0004
637 VASCULITIS 5 0.0004
638 LUNG DISORDER 21 0.0004
639 CARPAL TUNNEL SYNDROME 6 0.0004
640 SEXUAL DYSFUNCTION 5 0.0004
641 ANAEMIA 81 0.0004
642 OSTEOARTHRITIS 18 0.0004
643 HYPOCALCAEMIA 8 0.0004
644 CHRONIC KIDNEY DISEASE 32 0.0004
645 GASTRIC ULCER 8 0.0004
646 RED BLOOD CELL COUNT DECREASED 12 0.0004
647 BLOOD PRESSURE INCREASED 64 0.0004
648 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
649 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
650 POST PROCEDURAL COMPLICATION 8 0.0004
651 DRUG PRESCRIBING ERROR 8 0.0004
652 IRRITABILITY 25 0.0004
653 AFFECT LABILITY 4 0.0004
654 HYPERTENSION 88 0.0004
655 PRESCRIBED OVERDOSE 8 0.0004
656 NOCTURIA 5 0.0004
657 GASTROENTERITIS 6 0.0004
658 MIGRAINE 39 0.0004
659 NASAL CONGESTION 24 0.0004
660 RENAL DISORDER 19 0.0004
661 LIVER INJURY 10 0.0004
662 HYPOTHYROIDISM 13 0.0004
663 STEVENS-JOHNSON SYNDROME 9 0.0004
664 SINUS DISORDER 8 0.0004
665 PHARYNGITIS 5 0.0004
666 CYST 5 0.0004
667 ABNORMAL DREAMS 11 0.0004
668 HYPOAESTHESIA ORAL 6 0.0004
669 CHOLELITHIASIS 13 0.0004
670 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
671 TASTE DISORDER 8 0.0004
672 DIABETES MELLITUS 30 0.0004
673 INSURANCE ISSUE 6 0.0004
674 DEVICE RELATED INFECTION 6 0.0004
675 PULMONARY EMBOLISM 37 0.0004
676 THYROID DISORDER 6 0.0004
677 PAIN IN JAW 11 0.0004
678 WHEEZING 23 0.0004
679 LIMB DISCOMFORT 12 0.0004
680 GASTROENTERITIS VIRAL 7 0.0004
681 FEMUR FRACTURE 12 0.0004
682 INTENTIONAL DOSE OMISSION 11 0.0004
683 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
684 DIPLOPIA 10 0.0004
685 THROMBOCYTOPENIA 43 0.0004
686 HYPERGLYCAEMIA 14 0.0004
687 PANIC ATTACK 14 0.0004
688 PULMONARY HYPERTENSION 8 0.0004
689 NAUSEA 303 0.0004
690 TOOTH INFECTION 5 0.0004
691 ULCER 6 0.0004
692 EATING DISORDER 8 0.0004
693 ABDOMINAL PAIN 87 0.0004
694 MOVEMENT DISORDER 12 0.0004
695 NEPHROLITHIASIS 17 0.0004
696 HEART RATE DECREASED 13 0.0004
697 BACK DISORDER 6 0.0004
698 BLOOD URINE PRESENT 7 0.0004
699 PRODUCT DISPENSING ERROR 8 0.0004
700 DECREASED APPETITE 85 0.0004
701 METASTASES TO BONE 6 0.0004
702 BLOOD GLUCOSE FLUCTUATION 4 0.0004
703 MANIA 6 0.0004
704 CHOLESTASIS 7 0.0004
705 APHASIA 11 0.0004
706 DRUG INTOLERANCE 35 0.0004
707 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
708 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
709 DEMENTIA 10 0.0004
710 ORAL PAIN 8 0.0004
711 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
712 INTESTINAL PERFORATION 4 0.0004
713 FATIGUE 277 0.0004
714 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 64 0.0004
715 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
716 SEASONAL ALLERGY 5 0.0004
717 DYSURIA 13 0.0004
718 FALL 117 0.0004
719 UPPER LIMB FRACTURE 7 0.0004
720 ABORTION SPONTANEOUS 14 0.0003
721 EPISTAXIS 26 0.0003
722 BALANCE DISORDER 30 0.0003
723 MULTI-ORGAN FAILURE 6 0.0003
724 NEOPLASM PROGRESSION 12 0.0003
725 HAEMORRHAGE 36 0.0003
726 EYELID OEDEMA 4 0.0003
727 APATHY 5 0.0003
728 AMENORRHOEA 6 0.0003
729 NIGHT SWEATS 11 0.0003
730 SEPSIS 38 0.0003
731 DEPRESSED MOOD 18 0.0003
732 RIB FRACTURE 7 0.0003
733 BRONCHITIS 25 0.0003
734 GASTROINTESTINAL DISORDER 30 0.0003
735 DRUG EFFECT DECREASED 18 0.0003
736 FUNGAL INFECTION 11 0.0003
737 GENERAL PHYSICAL HEALTH DETERIORATION 38 0.0003
738 RETCHING 7 0.0003
739 MEMORY IMPAIRMENT 45 0.0003
740 IMPAIRED WORK ABILITY 7 0.0003
741 DRUG ADMINISTRATION ERROR 10 0.0003
742 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
743 HEADACHE 204 0.0003
744 CONJUNCTIVITIS 6 0.0003
745 THINKING ABNORMAL 6 0.0003
746 BACTERIAL INFECTION 6 0.0003
747 EYE PAIN 18 0.0003
748 URINARY TRACT INFECTION 54 0.0003
749 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
750 PROTEINURIA 6 0.0003
751 HAEMATEMESIS 8 0.0003
752 DEHYDRATION 42 0.0003
753 FEELING JITTERY 6 0.0003
754 PRODUCTIVE COUGH 15 0.0003
755 HYPOPHAGIA 8 0.0003
756 HEPATITIS 8 0.0003
757 INSOMNIA 83 0.0003
758 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
759 HIATUS HERNIA 4 0.0003
760 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
761 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
762 DYSPNOEA 174 0.0003
763 NERVOUSNESS 16 0.0003
764 MOBILITY DECREASED 22 0.0003
765 MUCOSAL INFLAMMATION 8 0.0003
766 DYSPHAGIA 29 0.0003
767 SPEECH DISORDER 16 0.0003
768 NEUROPATHY PERIPHERAL 29 0.0003
769 BEDRIDDEN 4 0.0003
770 UNEVALUABLE EVENT 23 0.0003
771 ADVERSE EVENT 28 0.0003
772 COGNITIVE DISORDER 14 0.0003
773 PRODUCT DOSE OMISSION ISSUE 88 0.0003
774 GAIT INABILITY 10 0.0003
775 MUSCULAR WEAKNESS 34 0.0003
776 PALPITATIONS 35 0.0003
777 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
778 FEELING ABNORMAL 71 0.0003
779 FEEDING DISORDER 6 0.0003
780 PAIN IN EXTREMITY 87 0.0003
781 HYPOAESTHESIA 44 0.0003
782 AKATHISIA 4 0.0003
783 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
784 INFLAMMATION 15 0.0003
785 MUSCULOSKELETAL DISCOMFORT 5 0.0003
786 LOCALISED INFECTION 7 0.0003
787 POLLAKIURIA 12 0.0003
788 FEELING COLD 8 0.0003
789 MOUTH ULCERATION 6 0.0003
790 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
791 PANCREATITIS 15 0.0003
792 ABASIA 7 0.0003
793 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
794 LYMPHADENOPATHY 10 0.0003
795 ANGINA PECTORIS 8 0.0003
796 BLOOD CHOLESTEROL INCREASED 13 0.0003
797 SEPTIC SHOCK 12 0.0003
798 CARDIOVASCULAR DISORDER 7 0.0003
799 HYPOKINESIA 4 0.0003
800 MYOCARDIAL INFARCTION 48 0.0003
801 C-REACTIVE PROTEIN INCREASED 10 0.0003
802 DYSSTASIA 8 0.0003
803 RENAL IMPAIRMENT 23 0.0003
804 MALAISE 120 0.0003
805 PRODUCT USE ISSUE 51 0.0003
806 ASTHENIA 102 0.0003
807 BLOOD GLUCOSE ABNORMAL 5 0.0003
808 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
809 ARTHROPATHY 15 0.0003
810 NEOPLASM MALIGNANT 18 0.0003
811 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
812 SWELLING 25 0.0003
813 ARTHRITIS 21 0.0003
814 ANHEDONIA 7 0.0003
815 PYREXIA 92 0.0003
816 PHOTOPHOBIA 5 0.0003
817 FLUSHING 27 0.0003
818 HEART RATE IRREGULAR 6 0.0003
819 BLOOD COUNT ABNORMAL 4 0.0003
820 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
821 ABDOMINAL DISCOMFORT 44 0.0003
822 ABDOMINAL PAIN UPPER 54 0.0003
823 PRODUCT USE IN UNAPPROVED INDICATION 65 0.0003
824 GASTRIC DISORDER 9 0.0003
825 INCREASED APPETITE 5 0.0003
826 CARDIAC FAILURE 21 0.0003
827 PULMONARY FIBROSIS 5 0.0003
828 GLAUCOMA 5 0.0003
829 PERICARDIAL EFFUSION 6 0.0003
830 RASH PRURITIC 14 0.0003
831 MOOD ALTERED 7 0.0003
832 DYSPHONIA 15 0.0003
833 BONE PAIN 15 0.0003
834 SKIN LESION 7 0.0003
835 HEART RATE INCREASED 25 0.0003
836 INFLUENZA 28 0.0003
837 CONTUSION 24 0.0002
838 BLISTER 14 0.0002
839 HYPONATRAEMIA 14 0.0002
840 CHILLS 29 0.0002
841 MYALGIA 42 0.0002
842 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
843 GAIT DISTURBANCE 47 0.0002
844 CEREBRAL INFARCTION 6 0.0002
845 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
846 BLOOD CREATININE INCREASED 16 0.0002
847 NEEDLE ISSUE 7 0.0002
848 ABDOMINAL DISTENSION 25 0.0002
849 HOT FLUSH 18 0.0002
850 SURGERY 14 0.0002
851 RENAL INJURY 7 0.0002
852 PLATELET COUNT DECREASED 25 0.0002
853 MUSCLE SPASMS 43 0.0002
854 HOSPITALISATION 36 0.0002
855 IRRITABLE BOWEL SYNDROME 5 0.0002
856 OCULAR HYPERAEMIA 11 0.0002
857 LACRIMATION INCREASED 7 0.0002
858 DEEP VEIN THROMBOSIS 15 0.0002
859 OFF LABEL USE 202 0.0002
860 RASH ERYTHEMATOUS 11 0.0002
861 DEAFNESS 6 0.0002
862 FLATULENCE 13 0.0002
863 EPILEPSY 7 0.0002
864 FEBRILE NEUTROPENIA 15 0.0002
865 LIVER DISORDER 10 0.0002
866 EAR INFECTION 6 0.0002
867 SWOLLEN TONGUE 7 0.0002
868 SNEEZING 5 0.0002
869 DIARRHOEA 143 0.0002
870 INFECTION 32 0.0002
871 LIMB INJURY 6 0.0002
872 DRY EYE 11 0.0002
873 CYSTITIS 7 0.0002
874 INFLUENZA LIKE ILLNESS 18 0.0002
875 DIZZINESS 109 0.0002
876 CEREBROVASCULAR ACCIDENT 37 0.0002
877 HIP FRACTURE 7 0.0002
878 CONDITION AGGRAVATED 66 0.0002
879 RHINORRHOEA 14 0.0002
880 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
881 AGRANULOCYTOSIS 4 0.0002
882 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
883 IMPAIRED HEALING 7 0.0002
884 OSTEONECROSIS 7 0.0002
885 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
886 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
887 VIRAL INFECTION 7 0.0002
888 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
889 HEPATIC ENZYME INCREASED 14 0.0002
890 ASTHMA 23 0.0002
891 ARTHRALGIA 84 0.0002
892 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
893 THROAT IRRITATION 9 0.0002
894 BURNING SENSATION 14 0.0002
895 CYTOKINE RELEASE SYNDROME 4 0.0002
896 FULL BLOOD COUNT DECREASED 4 0.0002
897 STOMATITIS 12 0.0002
898 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
899 NEUTROPHIL COUNT DECREASED 8 0.0002
900 FEELING HOT 12 0.0002
901 PERIPHERAL SWELLING 30 0.0002
902 EMOTIONAL DISORDER 6 0.0002
903 DISEASE PROGRESSION 23 0.0002
904 GYNAECOMASTIA 6 0.0002
905 HAEMATOMA 5 0.0002
906 RESPIRATORY TRACT INFECTION 5 0.0002
907 DRUG INEFFECTIVE 253 0.0002
908 MUSCULOSKELETAL PAIN 10 0.0002
909 JOINT STIFFNESS 5 0.0002
910 RASH 81 0.0002
911 FREQUENT BOWEL MOVEMENTS 5 0.0002
912 COLITIS 7 0.0002
913 NASOPHARYNGITIS 34 0.0002
914 MUSCULOSKELETAL STIFFNESS 16 0.0002
915 DISCOMFORT 11 0.0002
916 LEUKOPENIA 9 0.0002
917 SKIN DISORDER 6 0.0002
918 HAEMOPTYSIS 5 0.0002
919 PARAESTHESIA 28 0.0002
920 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
921 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
922 CHEST DISCOMFORT 18 0.0002
923 INCORRECT DOSE ADMINISTERED 40 0.0002
924 TINNITUS 8 0.0002
925 LIVER FUNCTION TEST ABNORMAL 5 0.0002
926 COUGH 48 0.0002
927 LABORATORY TEST ABNORMAL 5 0.0002
928 BLOOD GLUCOSE DECREASED 8 0.0002
929 PRURITUS 64 0.0002
930 SKIN EXFOLIATION 14 0.0002
931 COVID-19 29 0.0002
932 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
933 BLOOD GLUCOSE INCREASED 31 0.0002
934 UNDERDOSE 12 0.0002
935 HAEMATOCHEZIA 9 0.0002
936 OROPHARYNGEAL PAIN 15 0.0002
937 CARDIAC FAILURE CONGESTIVE 13 0.0002
938 EYE SWELLING 6 0.0002
939 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
940 JOINT SWELLING 19 0.0002
941 DRUG RESISTANCE 4 0.0002
942 LACTIC ACIDOSIS 5 0.0002
943 SKIN DISCOLOURATION 7 0.0002
944 EYE DISORDER 5 0.0002
945 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
946 HAEMATURIA 5 0.0001
947 VISION BLURRED 20 0.0001
948 ATRIAL FIBRILLATION 14 0.0001
949 RASH MACULAR 5 0.0001
950 CEREBRAL HAEMORRHAGE 5 0.0001
951 PRODUCT SUBSTITUTION ISSUE 8 0.0001
952 FLUID RETENTION 7 0.0001
953 THROMBOSIS 11 0.0001
954 DYSGEUSIA 10 0.0001
955 HEPATIC FUNCTION ABNORMAL 5 0.0001
956 TREATMENT FAILURE 11 0.0001
957 INTERSTITIAL LUNG DISEASE 6 0.0001
958 HYPERSENSITIVITY 23 0.0001
959 SWELLING FACE 8 0.0001
960 PRODUCT DOSE OMISSION 8 0.0001
961 ADVERSE DRUG REACTION 11 0.0001
962 ALOPECIA 24 0.0001
963 INJECTION SITE ERYTHEMA 15 0.0001
964 THERAPEUTIC RESPONSE DECREASED 7 0.0001
965 VERTIGO 7 0.0001
966 ECZEMA 6 0.0001
967 COLITIS ULCERATIVE 5 0.0001
968 DEVICE ISSUE 10 0.0001
969 INJECTION SITE PAIN 34 0.0001
970 NEUTROPENIA 15 0.0001
971 INJECTION SITE MASS 4 0.0001
972 SINUSITIS 11 0.0001
973 ERYTHEMA 22 0.0001
974 DRY SKIN 14 0.0001
975 HERPES ZOSTER 6 0.0001
976 EYE IRRITATION 6 0.0001
977 CATARACT 6 0.0001
978 DEVICE BREAKAGE 4 0.0001
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
980 THERAPY INTERRUPTED 7 0.0001
981 DRUG DOSE OMISSION 16 0.0001
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
983 DEVICE DISLOCATION 4 0.0001
984 INJECTION SITE SWELLING 7 0.0001
985 URTICARIA 15 0.0001
986 PRODUCT QUALITY ISSUE 11 0.0001
987 RHEUMATOID ARTHRITIS 9 0.0001
988 NO ADVERSE EVENT 14 0.0001
989 ANAPHYLACTIC REACTION 4 0.0001
990 DEVICE MALFUNCTION 5 0.0001
991 BREAST CANCER 6 0.0001
992 INJECTION SITE BRUISING 5 0.0001
993 INJECTION SITE PRURITUS 4 0.0001
994 PRODUCT STORAGE ERROR 5 0.0001
995 PSORIASIS 5 0.0000